Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct 4;7(11):628-30.
doi: 10.1038/nrrheum.2011.152.

Connective tissue diseases: Predicting death in SSc: planning and cooperation are needed

Robyn T Domsic, Thomas A Medsger Jr

Connective tissue diseases: Predicting death in SSc: planning and cooperation are needed

Robyn T Domsic et al. Nat Rev Rheumatol. .

Abstract

Systemic sclerosis is associated with a high level of patient mortality. A promising prognostic model that could enable more effective management and improve survival was recently validated; however, the results demonstrate that choosing the best cohorts for development and validation of predictors of mortality is essential.

PubMed Disclaimer

References

    1. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann. Rheum. Dis. 2007;66:940–944. - PMC - PubMed
    1. Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin. Arthritis Rheum. 2010;39:269–277. - PubMed
    1. Nihtyanova S, et al. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM. 2010;103:109–115. - PubMed
    1. Fransen J, et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann. Rheum. Dis. 2011;70:1788–1792. - PubMed
    1. Bryan C, Howard Y, Brennan P, Black C, Silman A. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br. J Rheumatol. 1996;35:1122–1126. - PubMed